EPINEPHrine Pre-filled Syringes Recalled for Sterility Assurance Issue
Nephron Sterile Compounding Center is recalling 35,850 pre-filled syringes of EPINEPHrine Injection due to lack of sterility assurance. The affected syringes were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable medication with sterility concerns. No illnesses or hospitalizations have been reported. Per the rubric, when a hazard is theoretical with no reported injuries, the maximum score is 3.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling 35,850 pre-filled syringes of EPINEPHrine Injection, USP (0.1 mg/10 mL) due to a lack of assurance of sterility. The affected product includes lots EN2005A (expires 7/25/2022), EN2009A (expires 8/20/2022), and EN2010A (expires 9/13/2022).
The U.S. Food and Drug Administration (FDA) issued this Class II recall due to concerns that the manufacturing process did not adequately ensure sterility of the pre-filled syringes. These syringes were distributed nationwide throughout the United States.
Patients and healthcare providers who have these syringes should not use them and should contact their healthcare provider for information about obtaining a replacement medication.
The recalled product
- Product
- EPINEPHrine Injection, USP, 0.1 mg/10 mL (10 mcg/mL), 10 mL Pre-Filled Syringe, 5 x 10 mL Pre-filled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-544-10
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Hazard
- contamination
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lots: EN2005A
- Exp. 7/25/2022
- EN2009A
- Exp. 8/20/2022
- EN2010A
- Exp. 9/13/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27